Peter Lio

6.3k total citations · 1 hit paper
209 papers, 3.4k citations indexed

About

Peter Lio is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Peter Lio has authored 209 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Dermatology, 99 papers in Immunology and Allergy and 49 papers in Physiology. Recurrent topics in Peter Lio's work include Dermatology and Skin Diseases (141 papers), Allergic Rhinitis and Sensitization (75 papers) and Asthma and respiratory diseases (48 papers). Peter Lio is often cited by papers focused on Dermatology and Skin Diseases (141 papers), Allergic Rhinitis and Sensitization (75 papers) and Asthma and respiratory diseases (48 papers). Peter Lio collaborates with scholars based in United States, Germany and France. Peter Lio's co-authors include Vivian Y. Shi, Eric L. Simpson, Νikolaos Makris, Anne CC Lee, Kenneth K. Kwong, Bruce R. Rosen, Alexander Poellinger, Robert J. Thomas, Joseph F. Pasternak and Barbara L. Trommer and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and PEDIATRICS.

In The Last Decade

Peter Lio

183 papers receiving 3.3k citations

Hit Papers

Efficacy and Safety of Upadacitinib vs Dupilumab in Adult... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Lio United States 28 2.2k 1.5k 585 417 267 209 3.4k
Gil Yosipovitch United States 32 2.2k 1.0× 718 0.5× 573 1.0× 625 1.5× 282 1.1× 70 3.4k
Ulrike Raap Germany 38 1.7k 0.8× 1.1k 0.8× 1.0k 1.8× 1.3k 3.1× 942 3.5× 142 3.9k
C. Taïeb France 32 1.8k 0.8× 471 0.3× 238 0.4× 282 0.7× 314 1.2× 213 3.8k
Maurizio Rolando Italy 37 1.0k 0.5× 1.2k 0.8× 306 0.5× 123 0.3× 105 0.4× 146 5.8k
Jennifer P. Craig New Zealand 43 2.3k 1.1× 2.4k 1.7× 553 0.9× 163 0.4× 127 0.5× 192 10.7k
Mark B. Abelson United States 40 898 0.4× 2.1k 1.4× 479 0.8× 382 0.9× 940 3.5× 177 4.7k
D. Kalogeromitros Greece 27 901 0.4× 699 0.5× 532 0.9× 988 2.4× 1.1k 4.1× 63 3.2k
Murat Doğru Japan 60 2.6k 1.2× 3.0k 2.1× 843 1.4× 311 0.7× 360 1.3× 286 13.8k
Benjamin D. Sullivan United States 32 1.3k 0.6× 1.3k 0.9× 623 1.1× 255 0.6× 123 0.5× 77 5.8k
Hong Liang Tey Singapore 25 1.1k 0.5× 348 0.2× 287 0.5× 384 0.9× 320 1.2× 118 2.0k

Countries citing papers authored by Peter Lio

Since Specialization
Citations

This map shows the geographic impact of Peter Lio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lio more than expected).

Fields of papers citing papers by Peter Lio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lio. The network helps show where Peter Lio may publish in the future.

Co-authorship network of co-authors of Peter Lio

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lio. A scholar is included among the top collaborators of Peter Lio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lio. Peter Lio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lio, Peter, et al.. (2025). Skin-Immune-Neuro-Gastro-Endocrine (SINGE) System: Lighting the Fire on Atopic Dermatitis Research. Dermatology Practical & Conceptual. 15(4). 5329–5329.
2.
Lio, Peter, et al.. (2025). Dermatological Manifestations and Sebum Composition in Parkinson’s Disease. Dermatology Practical & Conceptual. 15(1). 4921–4921. 1 indexed citations
4.
Schachner, Lawrence A., Anneke Andriessen, Latanya Benjamin, et al.. (2024). Attenuation of Atopic Dermatitis in Newborns, Infants, and Children With Prescription Treatment and Ceramide-Containing Skin Care: A Systematic Literature Review and Consensus.. PubMed. 23(3). 152–159. 1 indexed citations
5.
Lio, Peter, et al.. (2024). Beautiful Bias from ChatGPT. PubMed Central. 2 indexed citations
7.
Lio, Peter, et al.. (2024). Combined Biologic and Surgical Interventions for Hidradenitis Suppurativa: A Systematic Review. Dermatologic Therapy. 2024(1). 1 indexed citations
8.
Simpson, Eric L., Pablo Fernández‐Peñas, Marjolein de Bruin‐Weller, et al.. (2024). Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2). Advances in Therapy. 42(1). 132–143. 3 indexed citations
9.
Negris, Olivia, Valéria Aoki, H. Aubert, et al.. (2024). The global reach of artificial intelligence in atopic dermatitis: The quality and reliability of ChatGPT responses in 8 languages. JAAD International. 17. 158–159.
10.
Lio, Peter, et al.. (2024). The role of the pediatric dermatologist in childhood bullying prevention and intervention: A call to action. Clinics in Dermatology. 42(5). 557–558.
11.
Silverberg, Jonathan I., Andreas Wollenberg, Linda Stein Gold, et al.. (2024). Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Dermatology and Therapy. 14(8). 2249–2260. 4 indexed citations
12.
Kwatra, Shawn G., Peter Lio, Stephan Weidinger, et al.. (2023). Patient preferences for atopic dermatitis treatments: a discrete choice experiment. Journal of Dermatological Treatment. 34(1). 2222201–2222201. 11 indexed citations
14.
Silverberg, Jonathan I., Christopher G. Bunick, Peter Lio, et al.. (2023). 427 Long-term 4-year safety of upadacitinib in moderate-to-severe atopic dermatitis: results of an integrated analysis of phase 3 studies. British Journal of Dermatology. 188(Supplement_3). 1 indexed citations
15.
Maghfour, Jalal, Matthew Szeto, Chandler W. Rundle, et al.. (2021). Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single‐centre randomized evaluator‐blinded clinical and in vitro studies in normal skin. Clinical and Experimental Dermatology. 46(8). 1518–1529. 16 indexed citations
16.
Lio, Peter, et al.. (2020). Acupuncture in Dermatology: An Update to a Systematic Review. The Journal of Alternative and Complementary Medicine. 27(1). 12–23. 13 indexed citations
17.
Lio, Peter, et al.. (2020). Cannabinoids in Dermatology: Hope or Hype?. Cannabis and Cannabinoid Research. 5(4). 279–282. 14 indexed citations
18.
Boguniewicz, Mark, Diamant Thaçi, Peter Lio, et al.. (2019). Dupilumab Improves Outcomes of Concurrent Asthma and Chronic Sino-Nasal Conditions in Patients With Atopic Dermatitis—a Pooled Analysis of Four Phase 3 Studies (LIBERTY AD SOLO 1 & 2, CHRONOS, and CAFÉ). Journal of Allergy and Clinical Immunology. 143(2). AB123–AB123. 4 indexed citations
19.
Clark, Ashley K., et al.. (2017). The Role of Polyphenols in Rosacea Treatment: A Systematic Review. The Journal of Alternative and Complementary Medicine. 23(12). 920–929. 9 indexed citations
20.
Lio, Peter, et al.. (2007). Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. Arthritis Care & Research. 59(1). 51–58. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026